Previous Article | Next Article ![]()
Journal of Clinical Microbiology, February 2007, p. 668-671, Vol. 45, No. 2
0095-1137/07/$08.00+0 doi:10.1128/JCM.01657-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
| CASE REPORT |
Department of Internal Medicine,1 Department of Surgery,2 Department of Pathology, Marshfield Clinic, Marshfield, Wisconsin,5 Molecular Microbiology Laboratory, Marshfield Clinic Research Foundation, Marshfield, Wisconsin,3 Marshfield Laboratories, Marshfield, Wisconsin4
Received 10 August 2006/ Returned for modification 12 August 2006/ Accepted 21 November 2006
|
|
|---|
|
|
|---|
![]() View larger version (95K): [in a new window] |
FIG. 1. (a) Appearance of the left leg on admission to the hospital. There is extensive erythema and purpura involving the entire left leg. Edema is present outside the area of erythema, and necrosis is developing along the medial aspect of the thigh. (b) Extensive necrosis of the leg. The infection rapidly progressed to frank necrosis of the skin and subcutaneous tissues, necessitating surgical debridement. (c) Histological appearance of deep subcutaneous tissue from surgical debridement. There is a dense inflammatory infiltrate of neutrophils, lymphocytes, and macrophages. A bacterial colony is present within the tissue (arrow). (d) Appearance of the left leg after two surgical debridement procedures. After extensive debridement the wounds were grafted with porcine skin. Despite continued antibiotic therapy his condition worsened and the patient required an above-the-knee amputation.
|
Microbiology.
A series of blood and tissue samples was obtained from the patient for microbiological culture during the course of treatment for necrotizing fasciitis. Blood samples were incubated in the BacT Alert System (bioMérieux, Durham, NC) to isolate the etiological agent. A small piece of tissue culture was directly processed for microbiological cultures. Bacterial identification and characterization of the suspected etiological agent were done by routine microbiological methods and 16S rRNA gene PCR and sequencing. Antibiogram susceptibilities were determined by the Vitek System (bioMérieux). The 16S rRNA and mecA gene PCR and sequencing were done by the method previously described (19, 20). PVL gene PCR was done by the method of Gillet et al. (8). The strain was genotyped by pulsed-field gel electrophoresis, multilocus sequence typing (MLST), and spa typing (3, 6, 13). Because this was a very unusual and persistent strain, a number of known toxin and virulence genes were screened for their presence in this strain. Staphylococcal enterotoxin genes sea, seb, sec, sed, see, seh, sej, sek, sel, egc, seg, sei, sem, sen, and seo; exfoliative toxin genes eta and etb; toxic shock syndrome toxin (TSST) gene tst; PVL gene lukSF-PV; and
-, ß-,
-, and
-hemolysin genes hla, hlb, hld, and hlg were tested. We also screened for seven newer virulence genes, bsa, ear, seg2, sel2, sec4, set16, and lpl10, that were reported to be uniquely associated with a hypervirulent Midwestern strain, MW2 (also known as USA400 MRSA clone) (2, 17). In addition, fibronectin binding protein genes fnaA and fnaB, collagen binding protein gene cna, intracellular adhesion gene icaA, clumping factor genes clfA and clfB, and adhesion factor genes sdrD and sdrE were also tested. All these virulence genes were tested by a series of multiplex and singleplex PCR assays (J. M. Brady and S. K. Shukla, unpublished data).
S. aureus was identified by colony morphology, Gram stain, and positive coagulase test and was confirmed by 16S rRNA gene PCR and sequencing. The bacterial isolate WI-MSSA184, recovered from the blood sample collected on the day of clinical presentation, was identified as S. aureus. A 734-bp sequence of the 16S rRNA gene of this isolate had 100% sequence identity with S. aureus strains, including a known virulent MSSA strain, MSSA476 (9).
The isolate showed susceptibility to the following antimicrobial agents: cefazolin, clindamycin, erythromycin, gentamicin, oxacillin, penicillin, tetracycline, trimethoprim-sulfamethoxazole, levofloxacin, linezolid, and amoxicillin-sulbactum. The SmaI macrorestricted pulsed-field gel electrophoresis pattern of the isolate was closely related to that of the type strain of the USA600 MRSA clone, except for the absence of the DNA fragment containing the mecA element (17). The MLST allelic profile (10-14-8-6-10-3-2) identified it as sequence type 45, which was consistent with the sequence type determined for the type strain USA600 clonal group. Typing by the surface protein A gene showed it to be spa type t917. As expected, the isolate was negative for the mecA gene and other genetic elements of staphylococcal cassette chromosome mec (SCCmec). The strain was also negative for leukocidin genes (lukSF-PV, lukE, and lukD), fnbB, exfoliative toxin genes (eta and etb), as well as enterotoxin genes (sea, seb, sec, sed, see, seh, sej, sek, and sel). However, the strain harbored
-, ß-,
-, and
-toxin genes and was positive for the egc genes (seg, sei, sem, sen, and seo) and the newer toxin genes bsa, set16, and lpl10. The strain was positive for clumping factors genes clfA and clfB, fibronectin binding protein gene fnbA, collagen binding adhesion gene cna, and intracellular adhesion gene icaA. The deep subcutaneous tissue obtained during surgical debridement showed a dense inflammatory infiltrate of neutrophils, lymphocytes, and macrophages as well as bacterial colonies within the tissue (Fig. 1C).
Necrotizing fasciitis is a syndrome predominantly due to polymicrobial infection and includes infection by pathogens such as Streptococcus pyogenes and species of Bacteroides, Clostridium, Peptostreptococcus, and members of Enterobacteriaceae. There have been rare reports of monobacterial necrotizing fasciitis caused by S. aureus. In all these reports, the clinical course was indolent. In this report, the course of infection was slow during the first few days but progressed rapidly thereafter to frank fascial necrosis. Despite proper antibiotic coverage, the patient required an above-the-knee amputation to prevent further necrosis. Usually when a patient presents with a soft-tissue infection and cultures due to S. aureus, the patient is more likely to have cellulitis than a necrotizing process. This case, along with the recently described cases, provides evidence that S. aureus should be added to the list of pathogens that can cause severe necrotizing fasciitis (16, 18, 21).
Severity of skin and soft-tissue infection caused by S. aureus, especially CA-MRSA, is dictated by its ability to produce tissue-necrotizing toxins and other virulence factors. One of the nearly ubiquitous toxins present in CA-MRSA is PVL, a two-component pore-forming toxin with the ability to cause necrotizing pneumonia (8). Besides the PVL genes, several other exotoxins and enterotoxins have been reported on the genomes of virulent strains of MRSA, including MW2, which caused a fatal illness in four children in 1997 to 1999 (5).
Kravitz et al. recently reported five cases (three of them fatal) of purpura fulminans, which were due to toxin-producing strains of S. aureus (15). One of these fatal cases was due to a PVL and staphylococcal enterotoxin C (SEC)-producing CA-MRSA strain of clone USA400. The four remaining cases were caused by other toxin (SEB, SEC, PVL, or TSST-1)-producing strains of CA-MSSA. Despite the numbers being relatively small, necrotizing fasciitis and purpura fulminans diseases could be viewed as examples of S. aureus-associated emerging illnesses. S. aureus that was reported to cause fatal cases of sepsis and Waterhouse-Friderichsen syndrome also produced PVL (1). Virulence profile results from these cases suggest that at least PVL, SEA, SEC, and TSST, either alone or in combination, play some role in diseases such as necrotizing pneumonia, necrotizing fasciitis, purpura fulminans, and Waterhouse-Friderichsen syndrome (1, 8, 15, 18).
S. aureus strains that caused purpura fulminans and Waterhouse-Friderichsen syndrome included both MSSA and MRSA phenotypes (1, 15). The severity of the disease due to a methicillin-sensitive strain described in this report prompted us to genotype this strain to see if it had molecular traits of known virulent strains of community-associated and/or health care-associated MRSA. Genotyping showed it to be related to a clonal type (USA600) observed in nosocomial settings (17). This strain belonged to ST45, a clone not previously reported to be hypervirulent. A search of the MLST database showed that ST45 has been found among nasal carriers and is associated with nosocomial infections. Both MRSA and MSSA ST45 phenotypes have been reported from several European countries and at least one case from New York (www.saureus.mlst.net). Even though the strain in this case was an ST45 type, it should be considered uncommon due to its susceptibility to penicillin. Given the severity of the necrotizing fasciitis, it was surprising to see that it lacked leukocidin genes lukD and lukE, tissue-necrotizing factor PVL, and genes for several superantigens (SEA, SEB, SEC, SED, SEE, SEH, SEJ, SEK, and SEL). The MSSA strain, WI-MSSA184, was positive for staphylococcal adhesin genes, clfA and clfB, that are capable of contributing to the initial attachment of the fascia followed by FnbA acting in the necrosis of fascia.
This strain's virulence likely came from a cluster of genes that belong to the superantigen family, the family of proteins capable of triggering a massive toxic shock response (14). We speculate that products of superantigen genes seg, sei, sem, sen, and seo played a role in the severity of the syndrome. Our understanding of staphylococcal egc is far from complete given the limited literature available on their role in pathogens. The egc genes belong to an operon and have been hypothesized to be a putative nursery of superantigens in S. aureus (12). However, toxins made by egc appear to be fewer in quantity than the classical enterotoxins (10), but EGC toxins are capable of evading immune response due to lack of neutralization by the human sera (7). In one study, egc was found to be less commonly present than sea in S. aureus strains that caused sepsis with or without septic shock (11). However, in another study, seg and sei, two egc genes, were implicated in causing staphylococcal toxic shock syndrome and staphylococcal scarlet fever (10). Interestingly, allelic variants of seg and sei have been recently described by Blaiotta et al. (4). It is possible that the proteins made by the allelic variant of egc could be more toxigenic than previously thought. In this context it seems plausible that EGC toxins could add to the severity of infections in certain compromised individuals. We speculate that the diabetic patient's immune response to the EGC toxins may have been inadequate. This case report serves as a sobering reminder to clinicians that initially benign-appearing soft-tissue infections caused by an MSSA harboring the appropriate virulence arsenal can progress to more severe disease, especially in compromised individuals. It also underscores the need for a better understanding of how virulence factors, especially egc, are associated with specific clinical syndromes.
We thank the Marshfield Clinic Research Foundation for its support through the assistance of Linda Weis and Alice Stargardt in the preparation of the manuscript.
Published ahead of print on 13 December 2006. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»